Hearing · house
“Stifling Innovation: Examining the Impacts of Regulatory Burdens on Small Businesses in Healthcare”
2024-05-08 · 14:00
Source status: Scheduled
Committee
Location
2360, Rayburn House Office Building
Witnesses
Mr. William Newell, J.D
Chief Executive Officer, Sutro Biopharma, Inc.
Dr. David Eagle, MD
Medical Oncologist & Chair of Legislative Affairs and Patient Advocacy, New York Cancer & Blood Specialists
Dr. Brian Miller, MD, MBA, MPH
Assistant Professor of Medicine, Johns Hopkins University School of Medicine
Dr. Diana Zuckerman
President, National Center for Health Research
Official published hearing
Congress.gov explicitly associates this publication with this proceeding.
H.Hrg.118-50
STIFLING INNOVATION: EXAMINING THE IMPACTS OF REGULATORY BURDENS ON SMALL BUSINESSES IN HEALTHCARE
No. 50 · 2024-05-08 · GovInfo record 2024-10-12
Documents
Witness documents
- Witness Biography · PDF
- Witness Truth in Testimony · PDF
- Witness Statement · PDF
- Witness Biography · PDF
- Witness Support Document · PDF
- Witness Statement · PDF
- Witness Truth in Testimony · PDF
- Witness Truth in Testimony · PDF
- Witness Statement · PDF
- Witness Truth in Testimony · PDF
- Witness Biography · PDF
- Witness Statement · PDF
- Witness Biography · PDF
Hearing record
Committee activity
- Hearing Memo · Support Document · PDF
- UC-Williams-Associated Builders and Contractors (ABC)-Letter for the Record · Support Document · PDF
- UC-Williams-American Academy of Dermatology Association (AAD)-Letter for the Record · Support Document · PDF
- UC-Williams-American Academy of Family Physicians (AAFP)-Letter for the Record · Support Document · PDF
- Hearing Notice · Support Document · PDF
Source: https://api.congress.gov/v3/committee-meeting/118/house/117237